Dr. Risa Wolf is an Associate Professor of Pediatrics in the Division of Pediatric Endocrinology at the Johns Hopkins University School of Medicine. Her research is focused on using innovative technologies to improve outcomes in pediatric diabetes. As the first investigator to implement artificial intelligence (AI) based diabetic retinopathy screening in the pediatric population, she has led studies on implementation, diagnostic accuracy and cost-effectiveness. In her NEI funded R01 studies, she is conducting multiple clinical trials to determine if autonomous AI based retinopathy screening improves overall screening rates and mitigates disparities in underserved youth with diabetes. She is experienced in implementation and validation studies of diagnostic AI, and has served as a member of the Collaborative Community for Ophthalmic Imaging on foundational principles for AI interpretation. Dr. Wolf is also the PI of trials to improve diabetes device and continuous glucose monitor uptake in youth with type 1 and type 2 diabetes and has led initiatives to improve uptake of diabetes technologies in the clinic setting.